82 related articles for article (PubMed ID: 4016763)
1. Biological nature of the effect of ascorbic acids on the growth of human leukemic cells.
Park CH
Cancer Res; 1985 Aug; 45(8):3969-73. PubMed ID: 4016763
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the growth enhancing effect of L-ascorbic acid on human leukemic cells in culture.
Park CH; Amare M; Hoogstraten B
Exp Hematol; 1980 Aug; 8(7):853-9. PubMed ID: 16398016
[TBL] [Abstract][Full Text] [Related]
3. In vitro growth modulation by L-ascorbic acid of colony-forming cells from bone marrow of patients with myelodysplastic syndromes.
Park CH; Kimler BF; Bodensteiner D; Lynch SR; Hassanein RS
Cancer Res; 1992 Aug; 52(16):4458-66. PubMed ID: 1643638
[TBL] [Abstract][Full Text] [Related]
4. Growth suppression of human leukemic cells in vitro by L-ascorbic acid.
Park CH; Amare M; Savin MA; Hoogstraten B
Cancer Res; 1980 Apr; 40(4):1062-5. PubMed ID: 6928398
[TBL] [Abstract][Full Text] [Related]
5. Growth modulation of human leukemic, preleukemic, and myeloma progenitor cells by L-ascorbic acid.
Park CH; Kimler BF
Am J Clin Nutr; 1991 Dec; 54(6 Suppl):1241S-1246S. PubMed ID: 1962577
[TBL] [Abstract][Full Text] [Related]
6. Vitamin C in leukemia and preleukemia cell growth.
Park CH
Prog Clin Biol Res; 1988; 259():321-30. PubMed ID: 3362876
[TBL] [Abstract][Full Text] [Related]
7. L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms.
Park S; Han SS; Park CH; Hahm ER; Lee SJ; Park HK; Lee SH; Kim WS; Jung CW; Park K; Riordan HD; Kimler BF; Kim K; Lee JH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2180-95. PubMed ID: 15313465
[TBL] [Abstract][Full Text] [Related]
8. A proteomic approach to the identification of early molecular targets changed by L-ascorbic acid in NB4 human leukemia cells.
Park S; Lee J; Yeom CH
J Cell Biochem; 2006 Dec; 99(6):1628-41. PubMed ID: 16927250
[TBL] [Abstract][Full Text] [Related]
9. Activation of Raf1 and the ERK pathway in response to l-ascorbic acid in acute myeloid leukemia cells.
Park S; Park CH; Hahm ER; Kim K; Kimler BF; Lee SJ; Park HK; Lee SH; Kim WS; Jung CW; Park K; Riordan HD; Lee JH
Cell Signal; 2005 Jan; 17(1):111-9. PubMed ID: 15451031
[TBL] [Abstract][Full Text] [Related]
10. L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.
Han SS; Kim K; Hahm ER; Lee SJ; Surh YJ; Park HK; Kim WS; Jung CW; Lee MH; Park K; Yang JH; Yoon SS; Riordan NH; Riordan HD; Kimler BF; Park CH; Lee JH; Park S
J Cell Biochem; 2004 Oct; 93(2):257-70. PubMed ID: 15368354
[TBL] [Abstract][Full Text] [Related]
11. Preferential growth inhibition of human leukemic versus normal myeloid colony-forming cells by 12-O-tetradecanoylphorbol-13-acetate.
Park CH
Exp Hematol; 1984 Jun; 12(5):285-90. PubMed ID: 6723821
[TBL] [Abstract][Full Text] [Related]
12. [Effect of hydroxyurea on the number of hematopoietic stem cells, stromal cell precursors and cell precursors of thymus lymphoid tissue in the bone marrow of mice during aging].
Sidorenko AV; Andrianova LF
Tsitologiia; 1984 Jul; 26(7):813-7. PubMed ID: 6485091
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic evaluation of chronic myeloid leukemia.
Moore MA; Mertelsmann R; Pelus LM
Blood Cells; 1981; 7(2):217-36. PubMed ID: 6945881
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
15. Growth promotion of human leukemic colonies in vitro with human malignant effusions.
Park CH; Stephens RL; Amare M
Anticancer Res; 1986; 6(2):187-90. PubMed ID: 3707054
[TBL] [Abstract][Full Text] [Related]
16. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
[TBL] [Abstract][Full Text] [Related]
17. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
18. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
19. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
20. In vitro differentiation of leukemic progenitor cells in various types of acute nonlymphocytic leukemia.
Ozawa K; Miura Y; Suda T; Motoyoshi K; Takaku F
Cancer Res; 1983 May; 43(5):2334-8. PubMed ID: 6187449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
